A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations

被引：0
|
作者：
Ferreira, J. J.
Rascol, O.
Poewe, W.
Sampaio, C.
Rocha, F.
Nunes, T.
Almeida, L.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
589
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Rasagiline in levodopa-treated Korean Parkinson's disease patients with motor fluctuations: Randomized, placebo-controlled, double-blind study
    Yun, Ji Young
    Jeon, Beom
    Kim, Jae Woo
    Lee, Chong
    Kim, Jong-Min
    Cho, Jin Whan
    Sohn, Young
    Lee, Jee-Young
    MOVEMENT DISORDERS, 2014, 29 : S33 - S33
  • [2] Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease
    Olanow, CW
    Kieburtz, K
    Stern, M
    Watts, R
    Langston, MW
    Guarnieri, M
    Hubble, J
    Atchison, P
    Bartel, D
    Bernik, C
    Bertoni, J
    Bharucha, K
    Blady, D
    Brandabur, M
    Chippendale, T
    Cleeremans, B
    Comella, C
    Counihan, T
    Durso, R
    Edelsohn, L
    Ellis, J
    Elmer, L
    Evans, B
    Forchetti, C
    Freeman, A
    Galvez-Jimenez, N
    Gazda, S
    Gollomp, S
    Gracies, J
    Greeley, D
    Harris, J
    Hauser, R
    Hershey, L
    Hoehn, M
    Hoffsteter, M
    Hormes, J
    Hubble, J
    Hutton, T
    Jankovic, J
    Kaminow, L
    Kassicieh, D
    Kirzinger, S
    Kishner, R
    Klapper, J
    Knox, C
    Koller, W
    Leonard, H
    Levin, K
    LeWitt, P
    Marcadis, A
    ARCHIVES OF NEUROLOGY, 2004, 61 (10) : 1563 - 1568
  • [3] Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with ''wearing-off'' phenomenon: a multicentre, double-blind, randomized, placebo-controlled trial
    Myllyla, VV
    Jackson, M
    Larsen, JP
    Baas, H
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 (04) : 333 - 341
  • [4] A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations - The PRESTO study
    Schwid, SR
    Shoulson, I
    Stern, M
    Oakes, D
    Kieburtz, K
    Fahn, S
    Blinclauer, K
    DeMarcaida, A
    Elmer, L
    Davis, K
    Fazzini, E
    Chin, L
    Scott, B
    Wilcox, C
    Colcher, A
    Reichwein, S
    Hauser, R
    Gauger, L
    Leehey, M
    Lewitt, P
    Kaminski, P
    Harrison, M
    Rost-Ruffner, E
    Racette, B
    Frei, K
    Luong, N
    Pahwa, R
    Dicarlo, J
    Kawai, C
    Jennings, D
    Caplan, K
    Fink, JS
    Novak, P
    Thomas, CA
    Chouinard, S
    Beauvais, C
    Tabbal, S
    Patterson, J
    Fernandez, H
    Bertoni, JM
    Skrypnik, L
    Panisset, M
    Fortin, MJ
    Molho, E
    Nash, J
    Dalvi, A
    Schwiterman, D
    Goetz, C
    Janko, K
    Mendis, T
    ARCHIVES OF NEUROLOGY, 2005, 62 (02) : 241 - 248
  • [5] Rasagiline as add on therapy in levodopa-treated patients with Parkinson's disease and motor fluctuations: A randomized placebo-controlled study
    Oztekin, N.
    Oztekin, F.
    Okkan, H.
    Ak, F.
    Bilen, S.
    MOVEMENT DISORDERS, 2009, 24 : S271 - S272
  • [6] Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial
    Rascol, O.
    Bronzova, J.
    Hauser, R. A.
    Lang, A. E.
    Sampaio, C.
    Theeuwes, A.
    Van de Witte, S. V.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (04) : 370 - 376
  • [7] Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
    Katzenschlager, Regina
    Poewe, Werner
    Rascol, Olivier
    Trenkwalder, Claudia
    Deuschl, Gunther
    Chaudhuri, K. Ray
    Henriksen, Tove
    van Laar, Teus
    Spivey, Kevin
    Vel, Senthil
    Staines, Harry
    Lees, Andrew
    LANCET NEUROLOGY, 2018, 17 (09): : 749 - 759
  • [8] Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
    Joaquim J. Ferreira
    Werner Poewe
    Olivier Rascol
    Fabrizio Stocchi
    Angelo Antonini
    Joana Moreira
    Ana Pereira
    José-Francisco Rocha
    Patrício Soares-da-Silva
    Neurology and Therapy, 2022, 11 : 1409 - 1425
  • [9] Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Moreira, Joana
    Pereira, Ana
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1409 - 1425
  • [10] A Double-Blind, Randomized, Placebo and Active-Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease
    Ferreira, Joaquim J.
    Rascol, Olivier
    Poewe, Werner
    Sampaio, Cristina
    Rocha, Jose-Francisco
    Nunes, Teresa
    Almeida, Luis
    Soares-da-Silva, Patricio
    CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (06) : 337 - 347
12345